Company Profile
Henan Huashang Pharmaceutical Co.,ltd. Was established in 2004 and located in Economic Development Zone of Zhecheng,Shangqiu,Henan Province. We are professional manufacturer on API and intermediates, with the total investment of 160million Chinese Yuan, and covering an area of 100,000 square meters. After several years development, it comes into being the industrial framework that mainly includes Sartan series API and Intermediates. The company has become the major supplier of many pharmaceutical companies in the America, EU,Asia etc. By our advanced technology, high quality and excellent service.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
5-(4'-Bromomethyl-1,1'-biphenyl-2-yl)-1-triphenylmethyl-1H-tetrazole |
1H-Tetrazole,5-[4′-(bromomethyl)[1,1′-biphenyl]-2-yl]-1-(triphenylmethyl)-;5-[4′-(Bromomethyl)[1,1′-biphenyl]-2-yl]-1-(triphenylmethyl)-1H-tetrazole;4′-Bromomethyl-2-(1-trityl-1H-tetrazol-5-yl)biphenyl;N-Triphenylmethyl-5-[2-(4′-bromomethylbiphenyl)]tetrazole;4-Bromomethyl-2′-[N-triphenylmethyl-1H-tetrazol-5-yl]biphenyl;4′-Bromomethyl-2-(1-triphenylmethyltetrazol-5-yl)biphenyl;[2′-(N-Trityltetrazol-5-yl)biphenyl-4-yl]methyl bromide;[2′-(1-Trityl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl bromide;[2′-(Triphenylmethyl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl bromide;4′-Bromomethyl-2-(N-trityl-1H-tetrazol-5-yl)biphenyl;N-Triphenylmethyl-5-[4′-(bromomethyl)biphenyl-2-yl]tetrazole;5-[4′-(Bromomethyl)biphenyl-2-yl]-N-(triphenylmethyl)tetrazole;4-[2′-(N-Triphenylmethyltetrazol-5-yl)phenyl]benzyl bromide;5-(4′-Bromomethylbiphenyl-2-yl)-1-trityl-1H-tetrazole;1-Triphenylmethyl-5-[4′-(bromomethyl)biphenyl-2-yl]tetrazole |
124750-51-2 | Inquiry | |
Argatroban |
2-Piperidinecarboxylic acid,1-[(2S)-5-[(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-,(2R,4R)-;2-Piperidinecarboxylic acid,1-[5-[(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-,[2R-[1(2S*),2α,4β]]-[partial]-;(2R,4R)-1-[(2S)-5-[(Aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid;MD 805;MCI 9038;Argipidine;Argatroban;Novastan;OM 805;GN 1600;Slonnon;DK 7419;MQPA;Acova;Argipidin;Argatra;78238-51-4;169554-65-8;172902-92-0 |
74863-84-6 | Inquiry | |
Candesartan cilexetil |
1H-Benzimidazole-7-carboxylic acid,2-ethoxy-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-,1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester;1H-Benzimidazole-7-carboxylic acid,2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-,1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester,(±)-;1H-Benzimidazole-7-carboxylic acid,2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-,1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester;TCV 116;(±)-1-Hydroxyethyl 2-ethoxy-1-[p-(o-1H-tetrazol-5-ylphenyl)l]-7-benzimidazolecarboxylate,cyclohexyl carbonate (ester);Candesartan cilexetil;Atacand;TCY 116;Blopress;2-Ethoxy-1-[(2′-(1H-tetrazol-5-yl)-1,1′-biphenyl-4-yl)methyl]-7-benzimidazolecarboxylic acid 1-(cyclohexyloxycarbonyloxy)ethyl ester;1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate;1-Cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate;1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-([4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl)-1H-1,3-benzodiazole-7-carboxylate;139481-74-6;198077-85-9;2050948-41-7 |
145040-37-5 | - / 99% | Inquiry |
Gliquidone |
Benzenesulfonamide,N-[(cyclohexylamino)carbonyl]-4-[2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-2(1H)-isoquinolinyl)ethyl]-;N-[(Cyclohexylamino)carbonyl]-4-[2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-2(1H)-isoquinolinyl)ethyl]benzenesulfonamide;Gliquidone;AR-DF 26;Glurenorm;ARDF 26SE;Beglynor;TangShiPing;TangShenPing;1-Cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxoisoquinolin-2-yl)ethyl]phenyl]sulfonylurea;1-Cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]benzenesulfonyl]urea;ZINC 01482077;ZINC 1482077;2411524-48-4 |
33342-05-1 | Inquiry | |
Irbesartan |
1,3-Diazaspiro[4.4]non-1-en-4-one,2-butyl-3-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-;1,3-Diazaspiro[4.4]non-1-en-4-one,2-butyl-3-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-;2-Butyl-3-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one;SR 47436;2-Butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4.4]non-1-en-4-one;Irbesartan;BMS 186295;Avapro;Aprovel;Karvea;2-Butyl-3-[[2′-(tetrazol-5-yl)biphenyl-4-yl]-methyl]-1,3-diazaspiro[4.4]non-1-en-4-one;Irbetan;Irbest;Kansartan;X-Tension;3-Butyl-2-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2,4-diazaspiro[4.4]non-3-en-1-one;2-Butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one;2-Butyl-3-[2′-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1,3-diaza-spiro[4.4]non-1-en-4-one;Sabervel;200762-06-7 |
138402-11-6 | Inquiry | |
Methyl 1-[(2'-cyanobiphenyl-4-yl)methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate |
1H-Benzimidazole-7-carboxylic acid,1-[(2′-cyano[1,1′-biphenyl]-4-yl)methyl]-2-ethoxy-,methyl ester;Methyl 1-[(2′-cyano[1,1′-biphenyl]-4-yl)methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate;Methyl 1-[(2′-cyanobiphenyl-4-yl)methyl]-2-ethoxybenzimidazole-7-carboxylate;1-[(2′-Cyano-1,1′-biphenyl-4-yl)methyl]-2-ethoxy-7-benzimidazolecarboxylic acid methyl ester;3-[(2′-Cyanobiphenyl-4-yl)methyl]-2-ethoxy-3H-benzimidazole-4-carboxylic acid methyl ester;875515-05-2 |
139481-44-0 | Inquiry | |
N-Methyl-2'-benzoyl-2,4'-dichloroacetanilide |
Acetamide,N-(2-benzoyl-4-chlorophenyl)-2-chloro-N-methyl-;Acetanilide,2′-benzoyl-2,4′-dichloro-N-methyl-;N-(2-Benzoyl-4-chlorophenyl)-2-chloro-N-methylacetamide;5-Chloro-2-(2-chloro-N-methylacetamido)benzophenone;N-Methyl-2′-benzoyl-2,4′-dichloroacetanilide |
6021-21-2 | Inquiry | |
Trityl candesartan |
1H-Benzimidazole-7-carboxylic acid,2-ethoxy-1-[[2′-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1′-biphenyl]-4-yl]methyl]-;2-Ethoxy-1-[[2′-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1′-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid;2-Ethoxy-1-[(2′-(1-trityl-1H-tetrazol-5-yl)-1,1′-biphenyl-4-yl)methyl]-7-benzimidazolecarboxylic acid;2-Ethoxy-1-((2′-(1-trityl-1H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylic acid |
139481-72-4 | Inquiry | |
Trityl candesartan cilexetil |
1H-Benzimidazole-7-carboxylic acid,2-ethoxy-1-[[2′-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1′-biphenyl]-4-yl]methyl]-,1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester;2-Ethoxy-1-[(2′-(1-trityl-1H-tetrazol-5-yl)-1,1′-biphenyl-4-yl)methyl]-7-benzimidazolecarboxylic acid 1-(cyclohexyloxycarbonyloxy)ethyl ester;Trityl candesartan cilexetil;N-Tritylcandesartan cilexetil;1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 2-ethoxy-1-((2′-(1-trityl-1H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate |
170791-09-0 | Inquiry |